Kyoto, Japan

Noriko Sasakawa

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kyoto University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriko Sasakawa. Retrieved from https://idiyas.com/inventor/noriko-sasakawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Noriko Sasakawa: Innovator in Genome Editing

Introduction

Noriko Sasakawa is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of genome editing, particularly through her innovative methods that enhance genetic research and applications.

Latest Patents

Noriko holds a patent for a groundbreaking method titled "Method for inducing exon skipping by genome editing." This method utilizes CRISPR-Cas technology along with guide RNA to skip a target exon of a gene of interest. The guide RNA is designed with a spacer sequence that positions the cleavage site within 80 bases from the splice donor site before the target exon or the splice acceptor site after the target exon. This innovative approach has the potential to advance genetic therapies and research.

Career Highlights

Noriko is affiliated with Kyoto University, where she conducts her research and develops her inventions. Her work has garnered attention for its potential applications in genetic engineering and therapeutic interventions.

Collaborations

Noriko collaborates with esteemed colleagues, including Hongmei Li and Akitsu Hotta, who contribute to her research endeavors and enhance the impact of her innovations.

Conclusion

Noriko Sasakawa's contributions to genome editing exemplify the power of innovation in science. Her patented methods are paving the way for advancements in genetic research and therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…